title: Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.
authors.forename: Curtis
authors.initials: C
authors.lastname: McKnight
authors.forename: Hossam
authors.initials: H
authors.lastname: Guirgis
authors.forename: Nick
authors.initials: N
authors.lastname: Votolato
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced / Q000235:genetics*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D005260:Female; D005838:Genotype; D059866:HLA-DQ beta-Chains / Q000235:genetics*; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D011618:Psychotic Disorders / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D059866:HLA-DQ beta-Chains; C069051:HLA-DQB1 antigen; D003024:Clozapine